Comparing The Efficacy of Sudhatatva Asthiposhak Tablets and Calcium with Vitamin D3 Tablets in Osteoporosis Treatment

Comparative efficacy study of Sudhatatva Asthiposhak tablet and calcium with vit d3 tablet in osteoporosis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081937

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M818- Other osteoporosis without currentpathological fracture

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Bone mineral density test Score below 1.5 The cases for carrying out BMD T Score will be screened with the following targeted patients: 1. Post menopausal woman with early menopause (40 years and below) and familial prevalence. 2. Patients with osteopenia or spinal deformities on spine xrays. 3. Patients on long term cortico steroids for more than six months 4. Patients with history of osteoporosis related fractures.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sr. Calcium and BMD Clinical assessment will be done at (0), at the end of 1st, 2nd and every subsequent month till the completion of treatment. The Lab investigations (Biochemical markers) will be recorded before drug administration (0 month) and after every two months till the completion of trial (0, 2M, 4th, 6th, i.e. the end of the treatment). The B.M.D. will be done before and after the completion of the treatment.Timepoint: Sr Calcium and BMD will be assessed 3 times 1st after 30days second after 60 days 3rd at 90 days	—

Measure

Time frame

Sr. Calcium and BMD Clinical assessment will be done at (0), at the end of 1st, 2nd and every subsequent month till the completion of treatment. The Lab investigations (Biochemical markers) will be recorded before drug administration (0 month) and after every two months till the completion of trial (0, 2M, 4th, 6th, i.e. the end of the treatment). The B.M.D. will be done before and after the completion of the treatment.Timepoint: Sr Calcium and BMD will be assessed 3 times 1st after 30days second after 60 days 3rd at 90 days

—

Secondary

Measure	Time frame
WOMAC scale will be assessed on first day then 30th day 60th day & 90th dayTimepoint: 30 days 60 days & 90 days	—

Countries

India

Contacts

Public ContactDr Parag Kulkarni

Dr D Y Patil College Of Ayurved and Research Center Pimpri

parag.kulkarni7@gmail.com9922653046

Outcome results